Arcellx, Inc. (ACLX)
NASDAQ: ACLX · Real-Time Price · USD
65.01
+2.95 (4.75%)
At close: Jan 7, 2026, 4:00 PM EST
65.07
+0.06 (0.09%)
After-hours: Jan 7, 2026, 7:56 PM EST
Arcellx Market Cap
Arcellx has a market cap or net worth of $3.76 billion as of January 7, 2026. Its market cap has decreased by -7.84% in one year.
Market Cap
3.76B
Enterprise Value
3.23B
1-Year Change
-7.84%
Ranking
Category
Stock Price
$65.01
Market Cap Chart
Since the IPO on February 4, 2022, Arcellx's market cap has increased from $503.15M to $3.76B, an increase of 647.10%. That is a compound annual growth rate of 66.96%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 6, 2026 | 3.59B | -4.82% |
| Dec 31, 2025 | 3.77B | -9.09% |
| Dec 31, 2024 | 4.15B | 43.89% |
| Dec 29, 2023 | 2.88B | 112.13% |
| Dec 30, 2022 | 1.36B | 170.02% |
| Feb 4, 2022 | 503.15M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 988.80B |
| Johnson & Johnson | 498.48B |
| AbbVie | 411.22B |
| UnitedHealth Group | 309.66B |
| AstraZeneca | 297.23B |
| Novartis AG | 273.49B |
| Merck & Co. | 269.67B |
| Novo Nordisk | 254.60B |